Abstract
In the past 10–15 years, policy makers in Hong Kong have started to turn their attention to Chinese medicine. This article reviews their progress to date, and examines the different regional policy models they might learn from in framing health care policies to cover both Chinese and modern scientific medicine. It argues that the best way forward for Hong Kong is to position itself on a spectrum of nondiscriminatory state practice that offers equal respect to both traditional and modern medicines. In East Asia, China stands towards one end of this spectrum, and South Korea and Taiwan towards the other. The article holds that Hong Kong should place itself somewhere between the two.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
